Translocator Protein (TSPO) as a Potential Biomarker in Human Cancers
AbstractTSPO is a receptor involved in the regulation of cellular proliferation, apoptosis and mitochondrial functions. Previous studies showed that the expression of TSPO protein correlated positively with tumour malignancy and negatively with patient survival. The aim of this study was to determine the transcription of Tspo mRNA in various types of normal and cancer tissues. In situ hybridization was performed to localise the Tspo mRNA in various human normal and cancer tissues. The relative level of Tspo mRNA was quantified using fluorescent intensity and visual estimation of colorimetric staining. RT-PCR was used to confirm these mRNA levels in normal lung, lung cancer, liver cancer, and cervical cancer cell lines. There was a significant increase in the level of transcription in liver, prostate, kidney, and brain cancers while a significant decrease was observed in cancers of the colon and lung. Quantitative RT-PCR confirmed that the mRNA levels of Tspo are higher in a normal lung cell line than in a lung cancer cell line. An increase in the expression levels of Tspo mRNA is not necessarily a good diagnostic biomarker in most cancers with changes not being large enough to be significantly different when detected by in situ hybridisation. View Full-Text
Share & Cite This Article
Bhoola, N.H.; Mbita, Z.; Hull, R.; Dlamini, Z. Translocator Protein (TSPO) as a Potential Biomarker in Human Cancers. Int. J. Mol. Sci. 2018, 19, 2176.
Bhoola NH, Mbita Z, Hull R, Dlamini Z. Translocator Protein (TSPO) as a Potential Biomarker in Human Cancers. International Journal of Molecular Sciences. 2018; 19(8):2176.Chicago/Turabian Style
Bhoola, Nimisha H.; Mbita, Zukile; Hull, Rodney; Dlamini, Zodwa. 2018. "Translocator Protein (TSPO) as a Potential Biomarker in Human Cancers." Int. J. Mol. Sci. 19, no. 8: 2176.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.